Мова оригіналу: Англійська
One issue that we continue to struggle with in the Turkish market is the relative price of MaterniT21 Plus in the territory and relative uptake that will be expected from a cash pay standpoint. We also have had several expressions of interest from other parties in the general region and we need to have some further discussions regarding diligence minimums and performance in light of the additional interest if Mas is still interested in exclusive access to the Turkish market.
Улюблені переклади
